ArticleCureus2025
Diagnosis of Isocitrate Dehydrogenase-Mutant Astrocytoma in the Subcallosal Gyrus Using T2-Fluid-Attenuated Inversion Recovery Mismatch Sign and Quantitative Magnetic Resonance Relaxometry.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Astrocytoma, isocitrate dehydrogenase (IDH)-mutant, is one of the intraparenchymal brain tumors, strictly defined by its molecular characteristics. This tumor type is typically found in the frontal, insular, and temporal lobes. Patients harboring this type of tumor benefit the most from aggressive tumor removal compared to other low-grade appearing gliomas. Thus, accurate preoperative diagnosis is crucial in providing these patients with the most efficient and effective treatment strategy. This case study presents a 40-year-old male with an IDH-mutant astrocytoma in the subcallosal gyrus, an unusual location. The diagnosis was aided by the presence of the "T2-FLAIR (fluid-attenuated inversion recovery) mismatch sign," a key radiological feature of IDH-mutant astrocytomas, accompanied by magnetic resonance (MR) relaxometry that allows quantitative tissue characterization. This case highlights the importance of combining qualitative imaging features, such as the T2-FLAIR mismatch sign, with quantitative data, such as MR relaxometry, for accurate diagnosis, especially in cases with unusual tumor locations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.